A new publication from Dr. James Hicks describing the utility of single-cell genomics from prostate biopsies towards improving diagnosis and prognosis in prostate cancer. See the Cancer Research article here.
The Kuhn and Hicks Laboratory at the USC Michelson Center for Convergent Bioscience (Los Angeles, CA) is looking for three postdoctoral fellows to focus on specific single cell and liquid biopsy projects in breast, lung and prostate cancer. Critical to being a successful candidate are the determination to improving outcomes for cancer patients through scientific... Read More
The Kuhn laboratory at USC will lead a Public-Private Partnership launched by the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium to evaluate liquid biopsies as biomarker in patients with colorectal cancer undergoing hepatic metastasectomy using the HD-SCA platform.
Convergence science has been pioneered in the field of oncology. However, other fields, such as neuroscience and psychiatry, are picking up on this approach of dealing with complexity. READ MORE
The Analytical Tools to Objectively Measure Human Performance (ATOM-HP) program is a two year pilot project between the National Cancer Institute’s Center for Strategic Initiatives and the Department of Defense’s Rapid Reaction Technology Office. Cancer patients and soldiers can each benefit from a quantitative and objective assessment of their physical status which is a key goal of the... Read More
The work entitled “SPATIOTEMPORAL PROGRESSION OF METASTATIC BREAST CANCER: A MARKOV CHAIN MODEL HIGHLIGHTING THE ROLE OF EARLY METASTATIC SITES” by Paul K. Newton, Jeremy Mason and colleagues is the featured article in the last edition of npj Breast Cancer. In this study, the authors found that spatiotemporal patterns of metastatic spread in breast cancer... Read More
Our own Breast Cancer Research Foundation (BCRF) researchers, Dr. Peter Kuhn and Dr. James Hicks, are featured in the Huffington Post. The liquid biopsy developed in the Kuhn-Hicks laboratory at the Bridge Institute at USC is an enabling technology that will improve risk assessment and individualized therapies for breast cancer patients losartan online. From the... Read More
Congratulations to our undergraduate students Serena Zheng, Joseph Bae and Sophia Wix! They were awarded Fall 2015 Provost’s Research Fellowships.
<a href="https://www losartan potassium.whitehouse.gov/blog/2015/10/08/increasing-use-data-science-us-department-veterans-affairs-medical-centers” target=”_blank”>Increasing the Use of Data Science in U.S. Department of Veterans Affairs Medical Centers: Last week, the U.S. Department of Veterans Affairs (VA) announced a new program aimed at improving patient outcomes through data science. In order to continue to deliver cutting-edge health care to our nation’s Veterans, VA launched the... Read More
Mark your calendars now for the workshop “QUANTIFYING HUMAN PERFORMANCE TO OPTIMIZE PATIENT OUTCOMES” (September 9th, 2015 | Bridge@USC) This program is a joint effort of the National Cancer Institute’s Center for Strategic Initiatives and the Department of Defense’s Rapid Response Technology Office losartan potassium 25mg. It is aimed at improving the lives of cancer... Read More